Vitamin D has attracted enormous interest over the past two decades. Many studies have linked low vitamin D levels to a wide range of diseases, fueling enthusiasm for testing and supplementation. But association is not the same as cause, and that distinction matters when deciding on whether to take vitamin D.
To bring clarity, the 2024 Endocrine Society Guideline took a careful, evidence-based approach. Rather than relying on observational studies alone, it prioritized results from randomized clinical trials – studies designed to answer whether vitamin D truly makes a difference. This approach helps separate signal from noise, especially in an area where strong opinions can sometimes outpace the data.
The result is a more nuanced view. Vitamin D has clear benefits in some situations, such as bone health and, for certain groups, in adults with prediabetes for diabetes prevention. But it is not a universal solution, and more is not always better. Vitamin D must be employed thoughtfully, guided by evidence, not enthusiasm.
